Financial incentive related to the administration of vaccines by GP practices

​Request ​741238083

Please provide details of any financial arrangements, payments, or incentive schemes that relate to the administration of vaccines by GP practices in Jersey.

Specifically, I would like to know: Whether GP practices in Jersey receive any direct payments, reimbursements, or financial incentives for administering childhood or adult vaccines.

If so, please provide the framework of these payments, including: 

The payment structure (e.g., per vaccine, per patient, or block funding). 

Whether the payments differ depending on the type of vaccine (e.g., routine childhood immunisations, COVID-19 vaccines, influenza vaccines). 

Whether these payments are linked to performance targets, uptake rates, or any other conditions. 

The total amount paid to GP practices collectively (not broken down by practice) in relation to vaccine administration in the last three financial years.

I am not seeking data that identifies individual GP practices or patients, only the overall policy and financial framework in place.

Response

Where GP practices assist in delivering vaccinations in the childhood vaccination programme, and seasonal flu vaccinations for children, a proportion of the appointment / service cost is recompensed from the Public Health budget. No charge is levied for the individual receiving the vaccination.

The specific detail of the service contract is deemed commercially sensitive, and Article 33 of the Freedom of Information (Jersey) Law 2011 has been applied to protect the commercial interests of parties to the contract.

Total payments made in respect of childhood vaccinations from 2023 to 2025 (to date) are:

2023: £ 185,620.73

2024: £ 190,790.20

2025: £ 95,263.96 (for the period January 2025 to September 2025 (Quarters 1 to 3))

No payments are made from Health and Care Jersey (which includes Public Health) for other vaccinations delivered by GP practices. Records are not held by Health and Care Jersey in respect of payments made by other Government Departments for GP services. Information on vaccines funded through the Health Insurance Fund, for example influenza vaccines, is held by Employment, Social Security and Housing.

Article applied

Article 33 Commercial interests

Information is qualified exempt information if –

(a) it constitutes a trade secret; or

(b) its disclosure would, or would be likely to, prejudice the commercial interests of a person (including the scheduled public authority holding the information).

Public Interest Test

Article 33 is a qualified exemption and, as such, Health and Care Jersey (HCJ) has conducted a public interest test as required by law.

When responding to requests of this nature, HCJ has to balance the public interest with the impact that disclosing this information would, or would be likely to, have upon the organisation and / or third parties. Whilst it may be in the public interest to understand the contracting of services, protecting commercially sensitive information is often necessary to ensure fairness and prevent harm to suppliers and / or the Government.

HCJ has assessed whether, in all the circumstances of the case, the public interest in supplying the information is outweighed by the prejudice that would likely result by doing so.

It is recognised that there is a public interest in transparency, particularly regarding Government contracts. However, having considered the public interest, HCJ has concluded that the public interest in disclosing details of the contractual arrangement is outweighed by the potential prejudice that would likely result.​​